Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Harvard Business School
US Department of Justice
Colorcon
Johnson and Johnson
Mallinckrodt
Queensland Health
Cantor Fitzgerald

Generated: December 12, 2018

DrugPatentWatch Database Preview

QMIIZ ODT Drug Profile

« Back to Dashboard

Which patents cover Qmiiz Odt, and when can generic versions of Qmiiz Odt launch?

Qmiiz Odt is a drug marketed by Tersera Theraps Llc and is included in one NDA. There is one patent protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in QMIIZ ODT is meloxicam. There are twenty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

Summary for QMIIZ ODT
International Patents:1
US Patents:1
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:QMIIZ ODT at DailyMed
Drug patent expirations by year for QMIIZ ODT

US Patents and Regulatory Information for QMIIZ ODT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc QMIIZ ODT meloxicam TABLET, ORALLY DISINTEGRATING;ORAL 211210-001 Oct 19, 2018 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tersera Theraps Llc QMIIZ ODT meloxicam TABLET, ORALLY DISINTEGRATING;ORAL 211210-002 Oct 19, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Boehringer Ingelheim
Daiichi Sankyo
Express Scripts
Harvard Business School
Cipla
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.